Communiqués Astellas Pharma Inc. Deutsche Boerse AG

Actions

YPHA

US04623U1025

Produits pharmaceutiques

Marché Fermé - Deutsche Boerse AG 08:07:55 28/09/2026			Varia. 5j.	Varia. 1 janv.
12,70 ^EUR	-1,55%		0,00%	+14,41%

24/09	Astellas Pharma Inc. administre le traitement au premier patient dans une étude de phase 3 de setidegrasib chez des patients atteints d’un cancer du poumon non à petites cellules avancé avec mutation KRAS G12D déjà traité	CI
17/09	Astellas Pharma Inc. annonce des changements au sein de sa direction	CI

Communiqués

24/09	Astellas Doses First Patient in Phase 3 Study of setidegrasib in Previously Treated KRAS G12D- Mutated Advanced Non-Small Cell Lung Cancer	AQ
06/08	South African Patent Ruling In Favour Of Astellas Pharma	AQ
09/04	Dyno Therapeutics Announces Capsid License Exercised by Astellas for Skeletal Muscle-Targeted Gene Delivery, Validating AI-Powered Technology for Biological Sequence Design	AQ
09/03	Astellas and Hovon Confirm Phase 3 Study Did not meet its Primary Endpoint of Overall Survival in Patients with Newly Diagnosed FLT3m+ AML	AQ
02/03	Astellas Pharma Inc. - PADCEV + Keytruda Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer	AQ
11/12	Astellas to Present New Clinical Data across Its Gastrointestinal Cancers Portfolio at 2026 ASCO GI Cancers Symposium	AQ
22/10/25	PADCEV (enfortumab vedotin-ejfv) Plus KEYTRUDA(R) (pembrolizumab) sBLA Granted FDA Priority Review for Treatment of Certain Patients with Muscle-Invasive Bladder Cancer	AQ
09/10/25	Astellas to Present New Data on IZERVAY in Geographic Atrophy at AAO 2025 Annual Meeting	AQ
26/09/25	China warns Japan businesses against spying after man convicted: sources	AQ
19/09/25	China tells Japan convicted man rewarded by intelligence agency	AQ
29/07/25	Ruling on Japanese businessman engaged in spying in China finalized	AQ
20/07/25	China pressed Japan businessman to admit to spying in plea deal	AQ
16/07/25	UPDATE1: Japan says detention of citizens in China hurting public sentiment	AQ
16/07/25	Japan says detention of citizens in China hurting public sentiment	AQ
16/07/25	UPDATE3: China court sentences Japanese man to 3.5-yrs in jail for spying	AQ
16/07/25	UPDATE2: Japanese man sentenced by China court to 3.5 yrs in prison for spying	AQ
16/07/25	Japanese man sentenced by China court to 3.5 yrs in prison for spying	AQ
16/07/25	China court to issue verdict in case of Japan man accused of spying	AQ
15/04/25	Chromatin Bioscience Signs Collaboration Agreement with Astellas	AQ
31/03/25	Japan envoy in China meets citizen detained for 2 yrs over espionage	AQ
13/02/25	U.S. FDA Approves Expanded Label for Astellas IZERVAY for Geographic Atrophy	AQ
06/02/25	Astellas Pharma Inc. - Recording of Extraordinary Losses in Non-consolidated Financial Results	AQ
09/01/25	Astellas Pharma, Inc. v. Sandoz Inc.	AQ
06/01/25	Astellas Pharma - China's National Medical Products Administration Approves VYLOY for First-Line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma	AQ
27/12/24	Axcelead DDP Enters into Drug Discovery Service Agreement with Astellas for Targeted Protein Degraders	AQ